Advertisement

Topics

ANI Pharmaceuticals Q1 Profit Down, Reaffirms FY17 View

09:09 EDT 4 May 2017 | FinanzNachrichten

WASHINGTON (dpa-AFX) - ANI Pharmaceuticals Inc. (ANIP, BPAX) Thursday reported derease in first quarter net income to $1.152 milion from $1.346 million in the prior year. On a per share basis, ear...

Original Article: ANI Pharmaceuticals Q1 Profit Down, Reaffirms FY17 View

NEXT ARTICLE

More From BioPortfolio on "ANI Pharmaceuticals Q1 Profit Down, Reaffirms FY17 View"

Quick Search
Advertisement